The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.
Winter in a cold climate can add challenges when caregiving for someone with dementia, columnist Ray Burow writes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback